JP2022527359A5 - - Google Patents
Info
- Publication number
- JP2022527359A5 JP2022527359A5 JP2021559187A JP2021559187A JP2022527359A5 JP 2022527359 A5 JP2022527359 A5 JP 2022527359A5 JP 2021559187 A JP2021559187 A JP 2021559187A JP 2021559187 A JP2021559187 A JP 2021559187A JP 2022527359 A5 JP2022527359 A5 JP 2022527359A5
- Authority
- JP
- Japan
- Prior art keywords
- drug
- use according
- isoxazoline
- sufficient
- life cycle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962829573P | 2019-04-04 | 2019-04-04 | |
| US62/829,573 | 2019-04-04 | ||
| PCT/IB2020/053229 WO2020202111A1 (en) | 2019-04-04 | 2020-04-03 | Systemic isoxazoline parasiticides for vector-borne and viral disease treatment or prophylaxis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022527359A JP2022527359A (ja) | 2022-06-01 |
| JP2022527359A5 true JP2022527359A5 (enExample) | 2023-04-10 |
Family
ID=72667108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559187A Pending JP2022527359A (ja) | 2019-04-04 | 2020-04-03 | 媒介動物媒介性疾患およびウイルス性疾患の治療または予防のための全身性イソキサゾリン系寄生虫駆除剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20220160682A1 (enExample) |
| EP (1) | EP3946325A4 (enExample) |
| JP (1) | JP2022527359A (enExample) |
| KR (1) | KR20220054241A (enExample) |
| CN (1) | CN113993518A (enExample) |
| AU (1) | AU2020251960A1 (enExample) |
| BR (1) | BR112021019931A2 (enExample) |
| CA (1) | CA3136042A1 (enExample) |
| IL (1) | IL286914A (enExample) |
| MX (1) | MX2021012188A (enExample) |
| WO (1) | WO2020202111A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016022066A1 (en) | 2014-08-04 | 2016-02-11 | Jerry Tan Eye Surgery Pte Ltd | Pharmaceutical compositions for demodex related blepharitis and eyelid crusting |
| AU2018385766B2 (en) | 2017-12-15 | 2022-12-01 | Tarsus Pharmaceuticals, Inc. | Isoxazoline parasiticide formulations and methods for treating blepharitis |
| US12502377B2 (en) | 2019-04-04 | 2025-12-23 | Tarsus Pharmaceuticals, Inc. | Method of eradicating ticks that attach to humans using lotilaner formulations |
| CN111265528A (zh) | 2020-01-21 | 2020-06-12 | 中国人民解放军军事科学院军事医学研究院 | 法匹拉韦在治疗冠状病毒感染方面的应用 |
| WO2022079496A1 (en) * | 2020-10-13 | 2022-04-21 | Menschlich Healthcare Opc Private Limited | A pharmaceutical composition of nitazoxanide, albendazole and pyrantel and method thereof |
| CN112294793B (zh) * | 2020-10-21 | 2022-03-22 | 青岛海洋生物医药研究院股份有限公司 | 氯生太尔或其药学上可接受的盐在制备用于预防和/或治疗冠状病毒感染的药物中的应用 |
| WO2022130031A1 (en) * | 2020-12-17 | 2022-06-23 | Chander Mohan Negi | A pharmaceutical composition of nitazoxanide and mefloquine and method thereof |
| CN114907354B (zh) * | 2021-02-07 | 2024-04-09 | 南京知和医药科技有限公司 | 一种磺酰胺类多环化合物及其制备方法与用途 |
| KR20250011119A (ko) * | 2022-05-16 | 2025-01-21 | 신젠타 크롭 프로텍션 아게 | 모기 방제 방법 |
| WO2024168149A1 (en) * | 2023-02-10 | 2024-08-15 | Tarsus Pharmaceuticals, Inc. | Isoxazoline parasiticide formulations and methods for treating blepharitis |
| US20240366572A1 (en) * | 2023-05-07 | 2024-11-07 | Michael Farber | Isoxazoline complexes and compositions thereof |
| US11903962B1 (en) * | 2023-05-07 | 2024-02-20 | Michael Farber | Isoxazoline complexes and compositions thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI556741B (zh) * | 2007-08-17 | 2016-11-11 | 英特威特國際股份有限公司 | 異唑啉組成物及其作為抗寄生蟲藥上的應用 |
| US8313752B2 (en) * | 2009-04-14 | 2012-11-20 | Merial Limited | Macrocyclic lactone combination compositions, vaccines and methods for producing same |
| MX2019005040A (es) * | 2016-10-31 | 2019-10-30 | Tropiq Health Sciences | Métodos y composiciones para prevenir la transmisión de enfermedades vectoriales. |
| EP4487846A3 (en) * | 2018-09-05 | 2025-03-19 | Zoetis Services LLC | Palatable antiparasitic formulations |
| EP4003292A1 (en) * | 2019-07-22 | 2022-06-01 | Intervet International B.V. | Soft chewable veterinary dosage form |
-
2020
- 2020-04-03 BR BR112021019931A patent/BR112021019931A2/pt unknown
- 2020-04-03 CA CA3136042A patent/CA3136042A1/en active Pending
- 2020-04-03 MX MX2021012188A patent/MX2021012188A/es unknown
- 2020-04-03 CN CN202080041597.8A patent/CN113993518A/zh active Pending
- 2020-04-03 EP EP20784367.3A patent/EP3946325A4/en active Pending
- 2020-04-03 KR KR1020217036211A patent/KR20220054241A/ko active Pending
- 2020-04-03 AU AU2020251960A patent/AU2020251960A1/en active Pending
- 2020-04-03 WO PCT/IB2020/053229 patent/WO2020202111A1/en not_active Ceased
- 2020-04-03 US US17/594,144 patent/US20220160682A1/en not_active Abandoned
- 2020-04-03 JP JP2021559187A patent/JP2022527359A/ja active Pending
-
2021
- 2021-10-03 IL IL286914A patent/IL286914A/en unknown
-
2023
- 2023-03-15 US US18/184,513 patent/US20230218584A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527359A5 (enExample) | ||
| US11072648B2 (en) | Mast cell stabilizers for treatment of fever | |
| JP2021527092A5 (enExample) | ||
| RU2329050C2 (ru) | Комбинация ингибиторов цитохром-р450-зависимых протеаз | |
| Zhang et al. | Current targeted therapeutics against COVID-19: based on first-line experience in China | |
| JP2017514911A5 (enExample) | ||
| CN108697727A (zh) | 治疗和预防hiv和aids的方法 | |
| JPWO2023054732A5 (enExample) | ||
| US7867523B2 (en) | Pharmaceutical composition | |
| CA2525202A1 (en) | Use of alpha interferon, ribavirin, dsrna and neuraminidase inhibitors to treat avian influenza | |
| Henderson | Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus type 1: current status and prospects for the future | |
| EP1476160B1 (en) | Pharmaceutical combination of artesunate and mefloquine for therapy of malaria | |
| TWI282735B (en) | Combination and pharmaceutical formulation for the treatment of HBV infection | |
| RU2021129948A (ru) | Системные изоксазолиновые паразитициды для лечения или профилактики трансмиссивных и вирусных заболеваний | |
| JP2024531799A5 (enExample) | ||
| RU2138255C1 (ru) | Способ лечения заболеваний вирусной этиологии | |
| CN107648249B (zh) | 去半乳糖替告皂甙在制备防治流感病毒感染的药物中的应用 | |
| WO2022019742A1 (es) | Paquete farmaceutico para prevención y/o tratamiento de enfermedad por covid-19 y uso del mismo | |
| JP2022538449A5 (enExample) | ||
| Moqaddasi | Pharmacology of Drugs for Treatment of COVID-19 | |
| JPH04108731A (ja) | 抗エイズウイルス剤 | |
| Al-Noaemi Mohammed et al. | Drug Repositioning For The Prophylaxis And Treatment of COVID-19 | |
| US20170348330A1 (en) | Antiviral compound and analogues thereof for treatment or prevention of flavivirus dengue/zika infections | |
| Chopra et al. | Studies on the Action of Synthetic Antimalarial Drugs on Indian Strains of Malaria: Cilional in the Treatment of'Crescent Carriers' | |
| CN101327217A (zh) | 茚地那韦和氯喹在制备复方抗疟疾药物中的应用 |